Midomafetamine

亚甲二氧甲基苯丙胺

Report date: 2026/05/21 20:00:22

Base Information

Drug NameMidomafetamine
Drug Alias NameMDMA摇头丸Ecstasy3,4-methylenedioxymethamphetamineMethylenedioxymetamfetamine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonistsCentral nervous system stimulants
TargetsAdrenergic receptors
Therapy Area/IndicationsPharmaceutical aidsPsychotherapyStress Disorders, Post-Traumatic +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[6] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesMultidisciplinary Association For Psychedelic Studies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNuminus Wellness IncResilient PharmaceuticalsSunstone Therapies Inc +[23] 
Inactive CompaniesN/A
Active IndicationsPharmaceutical aidsStress Disorders, Post-TraumaticAdjustment Disorders +[13] 
Inactive IndicationsPsychotherapy

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG